Adaptive Biotechnologies Corp. (ADPT)

16.22 -0.20 (-1.19%) USD  |  NASDAQ  |  Dec 31, 16:00
16.26 +0.04 (+0.22%) After-Hours: 18:23
More

Adaptive Biotechnologies Current Deferred Revenue (Quarterly)

Current Deferred Revenue (Quarterly) Chart

View Current Deferred Revenue (Quarterly) for ADPT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Current Deferred Revenue (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Current Deferred Revenue (Quarterly) Range, Past 5 Years

View Current Deferred Revenue (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Current Deferred Revenue (Quarterly) Benchmarks

View Current Deferred Revenue (Quarterly) Benchmarks
Start Trial
Regeneron Pharmaceuticals, Inc. Upgrade
Zymeworks, Inc. Upgrade
Cue Biopharma, Inc. Upgrade
Recursion Pharmaceuticals, Inc. Upgrade
Arcellx, Inc. Upgrade